Cancer is an increasing cause of mortality and morbidity throughout the world. L-methionase has potential application against many types of
cancers. L-Methionase is an intracellular
enzyme in bacterial species, an extracellular
enzyme in fungi, and absent in mammals. L-Methionase producing bacterial strain(s) can be isolated by 5,5'-dithio-bis-(2-nitrobenzoic acid) as a screening
dye.
L-Methionine plays an important role in tumour cells. These cells become
methionine dependent and eventually follow apoptosis due to
methionine limitation in
cancer cells.
L-Methionine also plays an indispensable role in gene activation and inactivation due to hypermethylation and/or hypomethylation.
Membrane transporters such as GLUT1 and
ion channels like Na(2+), Ca(2+), K(+), and Cl(-) become overexpressed. Further, the α-subunit of
ATP synthase plays a role in
cancer cells growth and development by providing them enhanced nutritional requirements. Currently,
selenomethionine is also used as a
prodrug in
cancer therapy along with
enzyme methionase that converts
prodrug into active toxic chemical(s) that causes death of cancerous cells/tissue. More recently, fusion
protein (FP) consisting of L-methionase linked to
annexin-V has been used in
cancer therapy. The fusion
proteins have advantage that they have specificity only for
cancer cells and do not harm the normal cells.